A Tumor-Specific Membrane Protein Degradation Platform via Covalent Reaction-Induced Aggregation

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Covalent degradation strategy improves anticancer capacity in tumor cells, suggesting new cancer therapy methods.

MAIN FINDING: CMPATACs enable tumor-specific degradation of membrane proteins without relying on receptors.
KEY EVIDENCE: The approach effectively degrades various membrane proteins, including HER2 and EGFR, enhancing anticancer capacity.
APPROACH: The method utilizes covalent reactions to aggregate membrane proteins, targeting them for lysosomal degradation.
SIGNIFICANCE: This innovation expands the potential for degrading undruggable proteins in cancer therapy, offering new treatment avenues.

Xu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Covalent degradation strategy improves anticancer capacity in tumor cells, suggesting new cancer therapy methods.

MAIN FINDING: CMPATACs enable tumor-specific degradation of membrane proteins without relying on receptors.
KEY EVIDENCE: The approach effectively degrades various membrane proteins, including HER2 and EGFR, enhancing anticancer capacity.
APPROACH: The method utilizes covalent reactions to aggregate membrane proteins, targeting them for lysosomal degradation.
SIGNIFICANCE: This innovation expands the potential for degrading undruggable proteins in cancer therapy, offering new treatment avenues.

Xu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark